BISMUTH + ANTACID (CHEWABLE TABLETS) 262 MG
BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 675 MG · DIN 02240473 · PERRIGO INTERNATIONAL
Health Canada status: CANCELLED POST MARKET
What is BISMUTH + ANTACID (CHEWABLE TABLETS)?
BISMUTH + ANTACID (CHEWABLE TABLETS) 262 MG contains BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 675 MG. It is listed in the Health Canada Drug Product Database under DIN 02240473, held by PERRIGO INTERNATIONAL, supplied as TABLET (CHEWABLE) for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 22-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02240473 |
|---|---|
| Brand name | BISMUTH + ANTACID (CHEWABLE TABLETS) |
| Generic / active ingredient | BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 675 MG |
| Manufacturer | PERRIGO INTERNATIONAL |
| Strength | 262 MG |
| Dosage form | TABLET (CHEWABLE) |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A02AX ANTACIDS, OTHER COMBINATIONS |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 22-Jul-2021 |
| Original market date | 2000-04-17 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02240473 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2240473 |
| Brand name | BISMUTH + ANTACID (CHEWABLE TABLETS) |
| Active ingredient / INN | BISMUTH SUBSALICYLATE : 262 MG CALCIUM CARBONATE : 675 MG |
| ATC code | A02AX |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02 |
| AHFS class | 84:80.00 |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| Biosimilar biologic | No |
| Market authorization holder | PERRIGO INTERNATIONAL |
Which pack is which?
| Strength on the label | 262 MG |
|---|---|
| Dosage form | TABLET (CHEWABLE) |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A02AX ANTACIDS, OTHER COMBINATIONS. 2 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| PEPTO-BISMOL CHEWABLES | 350 MG | TABLET (CHEWABLE) | PROCTER & GAMBLE INC | MARKETED | DIN 02237315 |
| STOMACH RELIEF CHEWABLE TABLETS | 262 MG | TABLET (CHEWABLE) | GUARDIAN DRUG COMPANY INC | MARKETED | DIN 02389215 |
| ANTACID 2 TABLETS | 61 MG | TABLET | ADVERTISING UNLIMITED INC. (A.U.I.) | CANCELLED POST MARKET | DIN 01904310 |
| BISMED CHEWABLE TABLETS | 350 MG | TABLET | TECHNILAB PHARMA INC. | CANCELLED POST MARKET | DIN 00810509 |
| BISMUTH CHEWABLE TABLETS | 308 MG | TABLET | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | DIN 02243124 |
| BISMUTH TABLETS WITH CALCIUM CARBONATE | 350 MG | TABLET (CHEWABLE) | TANTA PHARMACEUTICALS INC | APPROVED | DIN 02317117 |
| CHERRY FLAVOUR PEPTO-BISMOL TAB | 262 MG | TABLET | PROCTER & GAMBLE INC | CANCELLED POST MARKET | DIN 01983725 |
| CHEWABLE BISMUTH TABLETS WITH CALCIUM CARBONATE | 262 MG | TABLET (CHEWABLE) | CELLCHEM PHARMACEUTICALS INC. | DORMANT | DIN 02319888 |
| MUCAINE - SUS | 100 MG / 5 ML | SUSPENSION | AURIUM PHARMA INC. | CANCELLED POST MARKET | DIN 02125013 |
| PEPTO-BISMOL TAB | 262 MG | TABLET | RICHARDSON-VICKS, DIVISION OF THE PROCTER & GAMBLE COMPANY | CANCELLED POST MARKET | DIN 00879037 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.